Keywords: aventis, completes, divestment, behring, csl, franco-german, drugmaker

Aventis completes divestment of Aventis Behring to CSL

Article | 05 April 2004

Print This

Franco-German drugmaker Aventis has announced the completion of the divestment of its therapeutic proteins business, Aventis Behring, to CSL Ltd.

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in